Microsoft Word dr. Abdulkadir turgut tez doc



Yüklə 0,64 Mb.
Pdf görüntüsü
səhifə65/65
tarix02.01.2022
ölçüsü0,64 Mb.
#2747
1   ...   57   58   59   60   61   62   63   64   65
 

 BPD:    Bronkopulmoner displazi 

 

 TTN:    Yenidoğanın geçici taşipnesi 

 

 ROP:    Prematüre retinopatisi 

     

 AST=SGOT: Aspartat Transaminaz 

     

 ALT=SGPT :Alanin Transaminaz 

    

 LDH:    Laktat dehidrogenaz 

    

    BUN:   Kan üre azotu 

    

 TDP:    Taze donmuş plazma 

 

 ARDS: Adult tip respiratuar distress sendrom 

 

 



 

 

 

 


 

84

KAYNAKLAR 

 

1-American College of Obstetricians and Gynecologists: Hypertension in 



pregnancy.  Washington,DC,The college; 1996, Technical Bulletin No. 219.  

 

2-National High Blood Pressure Education Working Group: High blood pressure    



during pregnancy. Am J Obstet Gynecol. 1990;163:1689-1712. 

 

3- National High Blood Pressure Education Program Working Group on High 



Blood Pressure in Pregnancy. Report of the National High Blood Pressure 

Education Program Working Group on High Blood Pressure in Pregnancy. Am J 

Obstet Gynecol 2000; 183: S1-S22. 

 

4- North RA, Taylor RS, Schellenberg JC. Evaluation of a definition of 



preeklampsia. Br J Obstet Gynecol 1999; 106: 767-73. 

 

5- Levine RJ, Ewell MG, Hauth JC, Curet LB, Catalano PM, Morris CD et al. 



Should the definition of preeklampsia include a rise in diastolic blood pressure ≥ 

15 mmHg to a level < 90 mmHg in association with proteinuria? Am J Obstet 

Gynecol 2000; 183: 787-92. 

 

6- Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, Hauth JC, Wenstrom 



KD. Williams Obstetric. 21 st Edition. New York, McGraw-Hill 2001; Chapter 24. 

 

7-Madazlı R., Özgön M., Aksu M.F., Köse Y.: Maternal Mortality in Cerrahpaşa 



Medical Faculty Department of Obstetrics and Gynecology and Intensive Care 

Unit. Weinstein D, Chervenak F (eds). The First World Congress on Maternal 

Mortality. Monduzzı Editore, 1997, pp 145-148 

 

8-American College of Obstetricians and Gynecologists.Manangement of 



preeclampsia. ACOG Technical Bulettin , 91, February, 1986 


 

85

 



9- Davey DA, MacGillivray I: The classification and defination of the 

hypertensive disorders of pregnancy.Am.J.Obstet. Gynecol. 158:892-98, 1988 

 

10-


 

Roberts Jm M. Pregnancy related hypertansion.(In): Creasy RK , Resnik R., 

eds. Maternal–Fetal Medicine. 5 th ed. Philedelphia: WB Saunders company

2004:859-99. 

 

11-Weinstein  L.Syndrome of hemolysis,elevated liver enzymes,and low platelet 



count:a severe consequence of hypertension in pregnancy. 

Am.J.Obstet.Gynecol. 1982;142:159-167. 

 

12-Hauth JC, Ewell MG, Levine RJ, Esterlitz JR, Sibai B, Curet LB, Catalano 



PM, Morris CD: Pregnancy outcomes in healthy nulliparas who developed 

hypertension. Obstet Gynecol 2000 95:24. 

 

13- Chesley LC, Cooper DW: Genetics of hypertension in pregnancy: Possible 



single gene control of preeclampsia and eclampsia in the descendants of 

eclamptic women. Br J Obstet Gynecol 1986, 93:898-908 

 

14- Adi-Said D, Annegers JF, Combs-Cantrell D, et al. Case-control study of the 



risk factors for preeclampsia. Am J Epidemiol. 1995; 142: 437-41. 

 

15-



.

Freidman EA, Neff RK. Pregnancy Hypertension. A systemic evaluation of 

clinical diagnostic criteria . littleton :psg Publishing Company Inc. 1977 

 

16- Saftlas AF, Olson DR, Franks AL. Epidemiology of preeclampsia and 

eclampsia in teh United States 1979-1986. Am J Obstet Gynecol 1990;163:460-

465 


 

17-Eskanazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for 

preeclampsia. J Am Med Assoc. 1991;266:237-71. 



 

86

 



18-Dekker GA, Sibai BM. Pathogenesis and etiology of preeklampsia. Am J 

Obstet Gynecol 1998; 179: 1359. 

 

19- Pijnenborg R. Trophoblast invasion. Reprod Med Review 1994; 3: 53-73. 



 

20- Zhou Y, Fisher SJ, Janatpour M, Dejena E, Wheelock M, Damsky 

CH.Human cytotrophoblasts adopt a vascular phenotype as they differentiate: a 

strategy for succesful endovascular invasion? J Clin Invest 1997; 99: 2139-51. 

 

21-Zhou Y, Damsky CH, Chiu K, Roberts JM, Fisher SJ. Preeklampsia is 



associated with abnormal expression of adhesion molecules by invasive 

cytotrophoblasts. J Clin Invest 1993; 91: 950-60. 

 

22- Fox H. The placenta in pregnancy hypertension. In: Rubin PC, 



ed.Handbook of hypertension,volume 10: hypertension in pregnancy.New York, 

Elsevier, 1998: 16-37 

 

23- Pijenborg R, Anthony J, Davey DA Tiltman A, Vercruysse L, van Assche A. 



Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J 

Obstet Gyneacol 1991; 98: 648-55. 

 

24-Kupferminc MJ, Fait G, Many A, Gordon D; Eldor A, Lessing JB.Severe 



preeklamsia and high frequency of genetic trombophilic mutations. Obstet 

Gynecol 2000; 96: 45-9. 

 

25-Schjetlein R, Abdelnoor M, Haugen G, Husby H, Sandset PM, Wisloff F. 



Hemostatic variables as independent predictors for fetal growth retardation in 

preeklampsia. Acta Obstet Gynecol Scand 1999; 78: 191-7. 

 



 

87

26- Pritchard JA, Cunningham FG, Pritchard SA. The Parkland Memorial 



Hospital protocol for treatment of eklampsia: evaluation of 245 cases.Am J 

Obstet Gynecol 1984; 148: 951-63. 

 

27- American College of Obstetricians and Gynecologists. Diagnosis and 



management of preeklampsia and eklampsia. ACOG Practice 

Bulletin.Number33, January2002. 

 

28- Ylikorkala O, Viinikka L. The role of prostaglandins in obstetrical disorders. 



Baillieres Clin Obstet Gyneacol. 1992; 6:809-27. 

 

29-Meagher EA, FitzGerald GA. Disordered eicosanoid formation in pregnancy- 



induced hypertension. Circulation. 1993; 88: 1324-33. 

 

30- Cotton DB, Lee W, Huhta JC.et al: hemodynamic profile of severe 



pregnancy-induced hypertension. Am J Obstet Gynecol 1988;158,523. 

 

31- Cotton DB, Gonik B, Dorman KF: Cardiovascular alterations in severe 



pregnancy-induced hypertension: acute effects of intravenosus magnesium 

sulfate. Am J Obstet Gynecol 1984;148,152 

 

32- Sibai BM, Spinnato JA, Watson DL, Lewis JA, Anderson GD. Eclampsia IV. 



Neurological findings and future outcome. Am J Obstet Gynecol. 1985 May 

15;152(2):184-92. 

 

33-Samuels P, Main AK, Tomaski A, Mennuli MT, Gabbe SG, Cines DB: 



Abnormalities in platelet antiglobulin tests in preeclamptic mothers and their 

neonates. Am J Obstet Gynecol 1987;157,69. 

 

34- Weiner CP, Brandt J. Plasma antitrombin III activity: An aid the diagnosis of 



preeclampsia-eclampsia. Am J Obstet Gynecol 1982;142,275. 

 



 

88

35- Bell WR: Disseminated intrvascular coagulation. Johns Hopkins Med J 



1980;146,189. 

 

36- Salch AA, Bottoms SF, Welch RA, Ali AM, Mariona FG, Mammom EF: 



Preeclampsia, delivery and the hemostatic system. Am J Obstet Gynecol 

1987;157,331. 

 

37-Spargo B, Mc Cartney CP, Winemiller R. Glomerular capillary endotheliosis 



in toxemia of pregnancy: current therapy. Obstet Gynecol. 1991 Feb;77(2):171-

5. 


 

38- Dennis EJ, Mc Farland KF, Hester LL: The Preeclampsia- eclampsia 

Syndrome. In Danforth DN(ed): Obstetrics and Gynecology (4th ed). Harper and 

Row, Philadelphia 1982, pp 455-474. 

 

39- Davison JM, Lindheimer MD: Hypertension in pregnancy. In Sciarra JJ (ed): 



Sciarra Gynecology and Obstetrics. The Williams Byrd Pres, Philadelphia 1987, 

vol 3 Chap 5, pp 1-27. 

 

40-Goodman RP, Killam AP, Brash AR, Branch RA: Prostacylin production 



during pregnancy: Comparison of production during normal pregnancy and 

pregnancy complicated by hypertension. Am J Obstet Gynecol 1982, 142:817-

821. 

 

41- Francoise M, Lionel S, Bernard LF, Laurence B, Gerard N, Jean CC and 



Paul G: Maternal serum human gonadotropin level at fifteen weeks is a 

predictor for preeclampsia. Am J Obstet Gynecol 1996;175,37-40. 

 

42-Hirai N, Yanahira T: Plasma levels of atrial natriuretic peptide during normal 



pregnancy and in pregnancy complicated by hypertension. Am J Obstet 

Gynecol 1988;159,27. 

 



 

89

43-Janes SL, Kyle PM, Redman C, et al. Flow cytometric detection of activated 



platelet in pregnant women prior to the development of preeclampsia. Thromb 

Haemost 1995;74:1059-63. 

 

44-Baker PN, Hackett GA. The use of urinary albumin –creatinine ratios and 



calcium-creatinine ratios as screening tests for pregnancy-induced 

hypertension. Obstet Gynecol. 1994 May;83(5 Pt 1):745-9. 

 

45- Rajkovic A, Mrcog KM, Malinow MR, et al. Plasma homocyst(e)in 



concentrations in eclamptic and preeclamptic African Women 

postpartum.Obstet Gynecol 1999;94:355. 

 

46-Talbert DG. Uterine flow velocity waveform shape as an indicator of 



maternal and placental development failure. Ultrasound Obstet Gynecol 

1995;6:261. 

 

47- Pritchard JA, Mac Donald PC, Gant NF: Williams Obstetrics (17th 



ed).Appleton Century-Crofts, Norwalk 1985. 

 

48-Benson RC: Gynecology and Obstetric. In Krupp MA, Chatton 



MJ(eds):Current Medical Diagnosis and Treatment. Lange Medical Publications

Los Altos 1975, pp 453-455. 

 

49-M.Nedim ÇİÇEK,Cemalettin AKYÜREK,Çetin ÇELİK,Ali HABERAL: Kadın 



Hastalıkları ve Doğum Bilgisi. 2. Baskı 2006. güneş kitabevi; Bölüm 39. 

 

50-Abramovici D, Friedman SA, Mercer BM, Audibert F, Kao L, Sibai BM. Am J 



Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does 

the HELLP (hemolysis, elevated liver enzymes, and low platelet count) 

syndrome matter?  Obstet Gynecol. 1999 Jan;180(1 Pt 1):221-5 

 



 

90

51- Steegers EAP, van der Post J. Hypertension in pregnancy. Textbook of 



Perinatal Medicine. Kurjak A (ED). Bath, UK, the Parthenon Publishing Group, 

1998: 1889-99 

 

52- Baha M.Sibai. Hypertension. (In): Gabbe SG , Niebly JR, Simpson JL,eds. 



Obstetrics Normal and problem pregnancies 4 th ed.Churcill Livingstone, 

2002:945-1004 

 

53- Sibai BM, Ramadan BK, Usta I, Salama M, Mercer BM, Friedman 



SA.Maternal morbidity and mortality in 442 pregnancies with hemolysis,elevated 

liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 

1993; 169: 1000-6. 

 

54- Isler CM, Rinehart BK, Terrone DA, Martin RW, Magann EF, Martin JN Jr. 



Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, 

and low platelets) syndrome. Am J Obstet Gynecol 1999; 181:924-28. 

 

55-Dekker G, Sibai B. Primary, secondary, and tertiary prevention of 



preeclampsia. 

Lancet 2001 Jan 20;357(9251):209-15 

 

56- Chappell LC, Seed PT, Briley AL, Kelly jJC, Lee R, Hunt BJ,et all. Effect of 



antioxidants on the occurrence of the preeclampsia in women at increased risk: 

a randomized trial. Lancet 1999;354:810-816 

 

57- Levine RJ, Hauth jJC, Curet LB, Sibai BM, Catalano PM, Morris CD, et al. 



Trial of calcium to prevent preeclampsia. N Engl J Med 1997;337:69-76 

 

58-Olsen SF, Secher nNJ, Tabor A, Weber T, Walker JJ, Gluud C.Randomized 



clinical trials of fish oil supplementation in high risk pregnancies. Br J Obstet 

Gynaecol 2000;107:382 

 



 

91

59-Klockenbusch W, Rath W. Prevention of pre-eclampsia by low-dose 



acetylsalicylic acid-a critical appraisal. Z Geburtshilfe Neonatol. 2002 Jul 

Aug;206(4):125-3 

 

60- Vainio M, Kujansuu E, Iso-Mustajarvi M, Maenpaa J. Low dose 



acetylsalicylic acid in prevention of pregnancy-induced hypertension and 

intrauterine growth retardation in women with bilateral uterine artery notches. 

BJOG 2002 Feb;109(2):161-7 

 

61- Ebrashy A, Ibrahim M, Marzook A, Yousef D. Usefulness of aspirin therapy 



in high-risk pregnant women with abnormal uterine artery doppler ultrasound at 

14-16 weeks pregnancy: randomized controlled clinical trial. Croat Med J 2005 

Oct;46(5):826 

 

62-Madazlı R, Gebelik ve hipertansiyon/ preeklampsi yönetimi. Maternal-fetal 



Tıp ve Perinatoloji Derneği Tanı ve Tedavi Kılavuzları 2005 Güneş Kitabevi 73-

79. 


 

63-Yang  JM and  Wang  KG:Relationship between acute fetal distress and 

maternal-palecental-fetal circulations in severe preeclampsia. Acta  Obstet. 

Gynecol. Scand. 74:419-424,1995. 

 

64-Thomson NF,Thorton S, Clark JF.The effects of placental extracts from 



normotensive and preeclamptic woman on vasoconstriction and oxidative 

metabolism. Am J Obstet Gynecol 2000;183:206-210. 

 

65- Garovic VD: Hypertension in Pregnancy: Diagnosis and Treatment;Mayo 



Clin Proc 2000;75:1071-1076. 

 

66-Magdy SM, Akolisa A, David G, et al.Preeclampsia and antioxidant nutrients: 



Decreased plasma levels of reduced ascorbic acid,  -tocopherol and 

betacarotene in women with preeclampsia. Am J Obstet Gynecol 1994; 

171:150-7. 



 

92

 



67- Sağol S, Özkınay E. Preeklampsi etyopatogenezinde lipid peroksidasyonu. 

Türkiye Klinikleri Jinekolojik Obstetrik Dergisi 2000; 10:7-15. 

 

68-Saphier  CJ.Repke  JT, Hemolysis,Elevated Liver Enzymes ,and Low 



Platelets(HELLP)Syndrome:A  Rewiev of diagnosis and managment .Seminar 

Perinatol 1998;22:118-133, 

 

69-Magann  EF,Martin  JN  Jr.Critical care of HELLP syndrome with 



corticosteroids. Am  J  Perinatol.2000;17:417-22. 

 

70-David K,James S,Philip J.Steer,Carl P.Weiner,Bernard Ganik  High Risk 



Pregnancy:managment options 2008 bölüm 50 Renal Bozukluklar syf 1104-

1105 


 

71-Chesley LC:Hypertensive disorders in pregnancy.New York,Appleton-

Century-Crofts,1978 

 

72-Caritis S,Sibai B,Hauth J,et al:Low-dose aspirin to prevent preeclampsia in 



women at high risk.National Instutute of Child Health and Human Development 

Network of Maternal-Fetal Units(see comments).N Engl J Med 338:701,1998  

 

73-Chesley LC:Hypertension in pregnancy:Definitions,familial factor,and remote 



prognosis.Kidney Intl 18:234,1980. 

 

74-Sibai BM,El-Nazer A,Gonzales-RuizA:Severe preeclampsia-eclampsia in 



young primigravid women:Subsequent pregnancy outcome and remote 

prognosis.Am J Obstet Gynecol 155:1011,1986.  

 

75-Martin JN Jr, Rinehart BK, May WL, Magann EF, Terrone DA, Blake PG:The 



spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, 

elevated liver enzyme levels, and low platelet count) syndrome 

classification.Am J Obstet Gynecol. 1999 Jun;180(6 Pt 1):1373-84.  



 

93

 



76-Haddad B, Barton JR, Livingston JC, Chahine R, Sibai BM.HELLP 

(hemolysis, elevated liver enzymes, and low platelet count) syndrome versus 

severe preeclampsia: onset at < or=28.0 weeks' gestation. Am J Obstet 

Gynecol 2000(a); 183:1475-9. 

 

77-Selahattin Kumru, Mehmet fiimflek, Bilgin Güratefl, Ekrem Sapmaz, Zeynep 



Özcan,Mehmet Nalbant, Denizmen Aygün: Comparison of Maternal and 

Perinatal Outcomes of HELLP Syndrome and Severe Preeclampsia Cases. 

Perinatal Journal • Vol: 13, Issue: 1/March 2005 

 

78-Harms K, Rath W, Herting E, Kuhn W. Maternal hemolysis, elevated liver 



enzymes, low platelet count and neonatal outcome.Am J Perinatol 

1995;1(12):1-6. 

 

79-Egerman RS,Sibai BM:HELLP syndrome.Clin Obstet Gynecol 42:381,1999 



 

80- Ching-Ming Liu, Shuenn-Dyh Chang, Po-Jen Cheng and An-Shine 

Chao:Comparisons of maternal and perinatal outcomes in Taiwanese women 

with complete and partial HELLP syndrome and women with severe pre-

eclampsia without HELLP. J. Obstet. Gynaecol. Res. Vol. 32, No. 6: 550–558, 

December 2006 

 

81-Raval DS, Co S, Reid MA, Pildes R. Maternal and neonatal outcome of 



pregnancies  complicated with maternal HELLP syndrome. J Perinatol  

1997; 17: 266-9. 

 

82-Ertan AK, Wagner S, Hendrik HJ, Tanriverdi HA, Schmidt W. Clinical and 



biophysical aspects of HELLP-syndrome. J Perinat Med 2002; 30: 483-9. 

 

83-van Pampus MG, Wolf H, Ilsen A, Treffers PE. Maternal outcome following 



temporizing management of the (H)ELLP syndrome. Hypertens Pregnancy 

2000; 19: 211-20. 




 

94

 



84-Deruelle P, Coudoux E, Ego A, Houfflin-Debarge V, Codaccioni X, Subtil D: 

Risk factors for post-partum complications occurring after preeclampsia and 

HELLP syndrome. A study in 453 consecutive pregnancies. Eur J Obstet 

Gynecol Reprod Biol. 2006 Mar 1;125(1):59-65. Epub 2005 Aug 22. 

 

85- Martin JN, Blake PG, Lowry SL, Perry KG, Files JC, Morrison JC.Pregnancy 



complicated by preeclampsia-eclampsia with the HELLP syndrome: how rapid 

is post partum recovery? Obstet Gynecol 1990;76:737-41. 

 

86-Sibai BM, Taslimi MM, El-Nazer A, Amon E, Mabie CB, Ryan GM. Maternal-



perinatal outcome associated with the syndrome of hemolysis, elevated liver 

enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet 

Gynecol 1986;155:501-9. 

 

87- Audibert F, Friedman SA, Frangieh AY, Sibai BM. Clinical utility of strict 



diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low 

platelets) syndrome. Am J Obstet Gynecol 1996;175:460-4. 

 

88- Reubinoff BE, Schenker JG. HELLP syndrome—a syndrome of hemolysis, 



elevated liver enzymes and low platelet count—complicating preeclampsia-

eclampsia. Int J Gynecol Obstet 1991;36:95-102. 

 

89- Geary M. The HELLP syndrome. Br J Obstet Gynaecol 1997;104:887-91. 



 

90-Mattar F,Sibai BM:Eclampsia:VIII.Risk factors for maternal morbidity.Am J 

Obstet Gynecol 182:307,2000. 

 

91-Martin Jr JN, Blake PG, Perry Jr KG, McCaul JF, Hess LW, Martin RW. The 



natural history of HELLP syndrome: patterns of disease progression and 

regression. Am J Obstet Gynecol 1991;164:1500–9. discussion 1509–13. 

 



 

95

92-Romero R, Mazor M, Lockwood CJ, et al. Clinical significance,prevalence 



and natural history of thrombocytopenia in pregnancyinduced hypertension. Am 

J Perinatol 1989;6:32–8. 

 

93-Haddad B, Barton JR, Livingston JC, Chahine R, Sibai BM. Risk factors for 



adverse maternal outcomes among women with HELLP (hemolysis, elevated 

liver enzymes, and low platelet count) syndrome.Am J Obstet Gynecol 

2000;183:444–8. 

 

94-Sibai BM. Diagnosis, controversies, and management of the syndrome of 



hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 

2004; 103: 981–989. 

 

95-Norwitz ER, Hsu SD, Repke JT. Acute complications preeclampsia.Clin 



Obstet Gynecol 2002; 45: 308–329 

 

96-S.Cansun Demir,MD,Cüneyt Evrüke,MD,Fatma T.Ozgunen,MD,İbrahim F. 



Urunsak,MD,Erdal Candan,MD,Oktay Kadayıfçı,MD:Factors that influence 

morbidity and mortality in severe preeclampsia,eclampsia and 

hemolysis,elevated liver enzymes,and low platetet count syndrome.Saudi Med J 

2006;Vol.27(7):1015-1018 

 

97-Magann EF, Martin JN Jr. Twelve steps to optimal management of HELLP 



syndrome. Clin Obstet Gynecol 1999;42:532-50 

 

98-James N. Martin, Jr, MD,a Warren L. May, PhD,b Everett F. Magann, MD,a 



Dom A. Terrone, MD,a Brian K. Rinehart, MD,a and Pamela G. Blake, RN, 

MSN: Early risk assessment of severe preeclampsia: Admission battery of 

symptoms and laboratory tests to predict likelihood of subsequent significant 

maternal morbidity. (Am J Obstet Gynecol 1999;180:1407-14.) 

 

99-Plouin PF,Chatellier G,Breart G, et al:Frequency and perinatal 



consequences of hypertensive disease of pregnancy.Adv Nephrol 57:69,1986. 


 

96

100-  Anumba DO, Robson SC. Management of pre-eclampsia and haemolysis, 



elevated liver enzymes, and low platelets syndrome. Curr Opin Obstet Gynecol 

1999;11:149–56. 

 

101 -Sibai BM, Taslimi M, Abdella TN, Brooks TF, Spinnato JA, Anderson GD. 



Maternal and perinatal outcome of conservative management of severe 

preeclampsia in midtrimester. Am J Obstet Gynecol 1985;152:32–7. 

 

102-Eeltink CM, van Lingen RA, Aarnoudse JG, Derks JB, Okken A.Maternal 



haemolysis, elevated liver enzymes and low platelets syndrome: specific 

problems in the newborn. Eur J Pediatr 1993;152:160-3. 

 

103-Killam AP, Dillard SH Jr, Patton RC, Pederson PR. Pregnancy-induced 



hypertension complicated by acute liver disease and disseminated intravascular 

coagulation: five case reports. Am J Obstet Gynecol 1975;123:823-8. 

 

104- van Dam PA, Renier M, Baekelandt M, Buytaert P, Byttenbroeck F. 



Disseminated intravascular coagulation and the syndrome of hemolysis, 

elevated liver enzymes, and low platelets in severe preeclampsia. Obstet 

Gynecol 1989;73:970-102. 

 

105- Magann EF, Perry KG, Chauhan SP, Graves GR, Blake PG, Martin JN Jr. 



Neonatal salvage by weeks’ gestation in pregnancies complicated by HELLP 

syndrome. J Soc Gynecol Invest 1994;1:206-9. 

 

106- Friedman SA, Schiff E, Kao L, Sibai BM. Neonatal outcome after preterm 



delivery for preeclampsia. Am J Obstet Gynecol 1995;172:1785-92. 

 

107- Van Bogaert LJ. Mortalite perinatale et preeclampsie/eclampsie:influence 



du HELLP syndrome sur la primigest. [Perinatal mortality and 

preeclampsia/eclampsia: influence of HELLP syndrome on the primigravida.] J 

Gynecol Obstet Biol Reprod (Paris) 1995;24:323-6 

 



 

97

108- Maria G. van Pampus, Hans Wolf, Steven M. Westenberg, Joris A.M. van 



der Post, Gouke J. Bonsel , Pieter E. Treffers: Maternal and perinatal outcome 

after expectant management of the HELLP syndrome compared with pre-

eclampsia without HELLP syndrome. European Journal of Obstetrics & 

Gynecology and Reproductive Biology 76 (1998) 31 –36 

 

109-Gleicher N, Boler LR, Norusis M, Del Granado A:Hypertensive diseases of 



pregnancy and parity .Am.J. Obstet. Gynecol. 154:1044-9,1986 

 

110-Brown CEL,Cunningham FG,Pritchard JA:Convulsions in hypertensive, 



proteinura primiparas more than 24 hours after delivery:Eclampsia or some 

other cause? J Reprod Med 32:499,1987  

 

111-Lubarsky SL,Barto JR,Friedman SA,Nasreddine S,Ramadan MK,Sibai 



BM:Late postpartum eclampsia revisited.Obstet Gynecol 83:502,1994 

 

112-Knuist M,Bonsel GJ,Zondervan HA,Treffers PE:Low sodium diet and 



pregnancy-induced hypertension:A multicentre randomized controlled trial.Br J 

Obstet Gynecol 105:430,1998 

 

113-Sibai BM,Ramadan MK,Chari RS,Friedman S:Prenancies complicated by 



HELLP syndrome(hemolysis,elevated liver enzymes,and low 

platelets):Subsequent pregnancy outcome and long-term prognosis.Am J 



Obstet Gynecol 172:125,1995  

 

Yüklə 0,64 Mb.

Dostları ilə paylaş:
1   ...   57   58   59   60   61   62   63   64   65




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©www.azkurs.org 2024
rəhbərliyinə müraciət

gir | qeydiyyatdan keç
    Ana səhifə


yükləyin